Arcadia Investment Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$110K Hold
3,000
0.02% 136
2025
Q4
$153K Hold
3,000
0.02% 127
2025
Q3
$166K Sell
3,000
-2,000
-40% -$117K 0.03% 122
2025
Q2
$345K Sell
5,000
-1,354
-21% -$92.1K 0.06% 98
2025
Q1
$441K Buy
6,354
+2,000
+46% +$165K 0.08% 94
2024
Q4
$375K Buy
4,354
+1,000
+30% +$108K 0.06% 99
2024
Q3
$399K Hold
3,354
0.07% 97
2024
Q2
$479K Hold
3,354
0.08% 87
2024
Q1
$431K Hold
3,354
0.08% 91
2023
Q4
$347K Hold
3,354
0.07% 99
2023
Q3
$305K Hold
3,354
0.06% 105
2023
Q2
$271K Buy
3,354
+1,354
+68% +$111K 0.06% 115
2023
Q1
$159K Hold
2,000
0.03% 147
2022
Q4
$135K Buy
+2,000
New +$117K 0.03% 157
2017
Q3
Sell
-170
Closed -$4K 384
2017
Q2
$4K Hold
170
﹤0.01% 349
2017
Q1
$3K Hold
170
﹤0.01% 415
2016
Q4
$3K Hold
170
﹤0.01% 309
2016
Q3
$4K Sell
170
-56
-25% -$1.39K ﹤0.01% 318
2016
Q2
$6K Sell
226
-748
-77% -$20.5K ﹤0.01% 423
2016
Q1
$26K Buy
974
+170
+21% +$4.55K 0.01% 201
2015
Q4
$23K Buy
+804
New +$22.3K 0.01% 210

Other funds holding NVO

Arcadia Investment Management's NVO Position: Q1 2026 in Review

Arcadia Investment Management held its Novo Nordisk (NVO) position steady in Q1 2026 at 3,000 shares worth $110K. The position accounts for 0.02% of the portfolio, ranked #136.

Arcadia Investment Management first reported a position in NVO in Q4 2015 and has held it in 21 quarters since. The position peaked at $479K in Q2 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Arcadia Investment Management held 3,000 shares of Novo Nordisk worth $110K as of Q1 2026.
  • Arcadia Investment Management left its Novo Nordisk share count unchanged in Q1 2026.
  • Novo Nordisk made up 0.02% of Arcadia Investment Management's portfolio in Q1 2026, its #136 holding.
  • Arcadia Investment Management first reported a position in Novo Nordisk in Q4 2015 and has held it in 21 quarters since.
  • Arcadia Investment Management's Novo Nordisk position peaked at $479K in Q2 2024.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Arcadia Investment Management's 13F filing for Q1 2026, filed 22 Apr 2026.